Stockreport

Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

Galecto, Inc.  (GLTO) 
PDF BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment [Read more]